294 related articles for article (PubMed ID: 23623266)
21. T-helper 2 cytokines, transforming growth factor β1, and eosinophil products induce fibrogenesis and alter muscle motility in patients with eosinophilic esophagitis.
Rieder F; Nonevski I; Ma J; Ouyang Z; West G; Protheroe C; DePetris G; Schirbel A; Lapinski J; Goldblum J; Bonfield T; Lopez R; Harnett K; Lee J; Hirano I; Falk G; Biancani P; Fiocchi C
Gastroenterology; 2014 May; 146(5):1266-77.e1-9. PubMed ID: 24486052
[TBL] [Abstract][Full Text] [Related]
22. Esophageal functional impairments in experimental eosinophilic esophagitis.
Mavi P; Rajavelu P; Rayapudi M; Paul RJ; Mishra A
Am J Physiol Gastrointest Liver Physiol; 2012 Jun; 302(11):G1347-55. PubMed ID: 22361731
[TBL] [Abstract][Full Text] [Related]
23. Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomised, placebo-controlled, double-blind trial.
Straumann A; Conus S; Grzonka P; Kita H; Kephart G; Bussmann C; Beglinger C; Smith DA; Patel J; Byrne M; Simon HU
Gut; 2010 Jan; 59(1):21-30. PubMed ID: 19828470
[TBL] [Abstract][Full Text] [Related]
24. Optimal Biopsy Protocol to Evaluate Histological Effectiveness of Proton Pump Inhibitor Therapy in Patients with Eosinophilic Esophagitis.
Fujiwara Y; Hashimoto A; Uemura R; Sawada A; Otani K; Tanaka F; Yamagami H; Tanigawa T; Watanabe T; Kabata D; Kuwae Y; Shintani A; Ohsawa M
Digestion; 2019; 100(1):64-71. PubMed ID: 30408792
[TBL] [Abstract][Full Text] [Related]
25. Eosinophilic esophagitis in adults is associated with IgG4 and not mediated by IgE.
Clayton F; Fang JC; Gleich GJ; Lucendo AJ; Olalla JM; Vinson LA; Lowichik A; Chen X; Emerson L; Cox K; O'Gorman MA; Peterson KA
Gastroenterology; 2014 Sep; 147(3):602-9. PubMed ID: 24907494
[TBL] [Abstract][Full Text] [Related]
26. Extracellular Eosinophil Granule Protein Deposition in Ringed Esophagus with Sparse Eosinophils.
Peterson KA; Cobell WJ; Clayton FC; Krishnamurthy C; Ying J; Pease LF; Saffari H; Georgelas A; Fang J; Gleich GJ; Leiferman KM
Dig Dis Sci; 2015 Sep; 60(9):2646-53. PubMed ID: 25902747
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of Dupilumab in a Phase 2 Randomized Trial of Adults With Active Eosinophilic Esophagitis.
Hirano I; Dellon ES; Hamilton JD; Collins MH; Peterson K; Chehade M; Schoepfer AM; Safroneeva E; Rothenberg ME; Falk GW; Assouline-Dayan Y; Zhao Q; Chen Z; Swanson BN; Pirozzi G; Mannent L; Graham NMH; Akinlade B; Stahl N; Yancopoulos GD; Radin A
Gastroenterology; 2020 Jan; 158(1):111-122.e10. PubMed ID: 31593702
[TBL] [Abstract][Full Text] [Related]
28. Predictors of histologic response to mepolizumab in pediatric eosinophilic esophagitis.
Wong ECL; Gleave AL; Marshall JK; Narula N
Eur J Gastroenterol Hepatol; 2023 Oct; 35(10):1131-1136. PubMed ID: 37577798
[TBL] [Abstract][Full Text] [Related]
29. Image Analysis of Eosinophil Peroxidase Immunohistochemistry for Diagnosis of Eosinophilic Esophagitis.
Wright BL; Doyle AD; Shim KP; Pai RK; Barshow SM; Horsley-Silva JL; Luo H; Rank MA; Jacobsen EA; Katzka DA; Kita H; Dellon ES
Dig Dis Sci; 2021 Mar; 66(3):775-783. PubMed ID: 32248390
[TBL] [Abstract][Full Text] [Related]
30. Eosinophilic oesophagitis: relevance of mast cell infiltration.
Strasser DS; Seger S; Bussmann C; Pierlot GM; Groenen PMA; Stalder AK; Straumann A
Histopathology; 2018 Sep; 73(3):454-463. PubMed ID: 29772120
[TBL] [Abstract][Full Text] [Related]
31. Pathogenic role of mast cells in experimental eosinophilic esophagitis.
Niranjan R; Mavi P; Rayapudi M; Dynda S; Mishra A
Am J Physiol Gastrointest Liver Physiol; 2013 Jun; 304(12):G1087-94. PubMed ID: 23599040
[TBL] [Abstract][Full Text] [Related]
32. Elevated IL-33 expression is associated with pediatric eosinophilic esophagitis, and exogenous IL-33 promotes eosinophilic esophagitis development in mice.
Judd LM; Heine RG; Menheniott TR; Buzzelli J; O'Brien-Simpson N; Pavlic D; O'Connor L; Al Gazali K; Hamilton O; Scurr M; Collison AM; Mattes J; Allen KJ; Giraud AS
Am J Physiol Gastrointest Liver Physiol; 2016 Jan; 310(1):G13-25. PubMed ID: 26514775
[TBL] [Abstract][Full Text] [Related]
33. Prostaglandin D2 receptor D-type prostanoid receptor 2 mediates eosinophil trafficking into the esophagus.
Zhang S; Wu X; Yu S
Dis Esophagus; 2014 Aug; 27(6):601-6. PubMed ID: 24165271
[TBL] [Abstract][Full Text] [Related]
34. Dietary treatment modulates mast cell phenotype, density, and activity in adult eosinophilic oesophagitis.
Arias Á; Lucendo AJ; Martínez-Fernández P; González-Castro AM; Fortea M; González-Cervera J; Yagüe-Compadre JL; Mota-Huertas T; Vicario M
Clin Exp Allergy; 2016 Jan; 46(1):78-91. PubMed ID: 25640519
[TBL] [Abstract][Full Text] [Related]
35. Eosinophilic esophagitis: epithelial mesenchymal transition contributes to esophageal remodeling and reverses with treatment.
Kagalwalla AF; Akhtar N; Woodruff SA; Rea BA; Masterson JC; Mukkada V; Parashette KR; Du J; Fillon S; Protheroe CA; Lee JJ; Amsden K; Melin-Aldana H; Capocelli KE; Furuta GT; Ackerman SJ
J Allergy Clin Immunol; 2012 May; 129(5):1387-1396.e7. PubMed ID: 22465212
[TBL] [Abstract][Full Text] [Related]
36. Normalized serum eosinophil peroxidase levels are inversely correlated with esophageal eosinophilia in eosinophilic esophagitis.
Wright BL; Ochkur SI; Olson NS; Shim KP; Jacobsen EA; Rank MA; Dellon ES; Lee JJ
Dis Esophagus; 2018 Feb; 31(2):. PubMed ID: 29228243
[TBL] [Abstract][Full Text] [Related]
37. Anti-IL-5 therapies for chronic obstructive pulmonary disease.
Donovan T; Milan SJ; Wang R; Banchoff E; Bradley P; Crossingham I
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013432. PubMed ID: 33295032
[TBL] [Abstract][Full Text] [Related]
38. Cellular and molecular immunological mechanisms in eosinophilic esophagitis: an updated overview of their clinical implications.
Lucendo AJ
Expert Rev Gastroenterol Hepatol; 2014 Aug; 8(6):669-85. PubMed ID: 24742298
[TBL] [Abstract][Full Text] [Related]
39. Electron microscopy elucidates eosinophil degranulation patterns in patients with eosinophilic esophagitis.
Saffari H; Hoffman LH; Peterson KA; Fang JC; Leiferman KM; Pease LF; Gleich GJ
J Allergy Clin Immunol; 2014 Jun; 133(6):1728-34.e1. PubMed ID: 24439077
[TBL] [Abstract][Full Text] [Related]
40. Mepolizumab: 240563, anti-IL-5 monoclonal antibody - GlaxoSmithKline, anti-interleukin-5 monoclonal antibody - GlaxoSmithKline, SB 240563.
Drugs R D; 2008; 9(2):125-30. PubMed ID: 18298130
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
